usp talc methods expert panel update - overview...expert panel that will conclude at the end of the...
TRANSCRIPT
3/30/2020
1
USP Talc Methods Expert Panel Update- Overview
Martin S. Rutstein, Ph.D. Co-chair, Talc Methods Expert Panel
March 13, 2020
1
2
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
2
3
© 2019 USP
Disclaimer
This presentation reflects the current work and recommendations of the USP Talc Expert Panels.
The content and views expressed do not necessarily reflect the policies of the U.S. Pharmacopeial Convention or the USP Council of Experts.
4
© 2019 USP
Agenda
Background – Talc usage and Test forAsbestos in Pharmaceutical Talc
Overview of FDA (CDER) Request to USP
Overview of USP Talc Expert Panels (#1 and#2) and published Stimuli articles to date
Overview of the Expert Panel #2 phasedapproach to test method selection, detection,and planned publication of future Stimuliarticle
4
© 2019 USP
ore TALC powder
SEM image TALC
ASBESTOS, variety
chrysotile
pharmaceuticals
3
4
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
3
5
© 2019 USP
Background - Talc Usage Very Widespread
Our focus
6
© 2019 USP
Background – Test for Asbestos in Pharmaceutical Talc
Characterizing the Productfor
“PURITY”
How do we measure & characterize the
elongateD “stuff” in
talcproducts?
5
6
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
4
7
© 2019 USP
Background – The USP Talc Monograph
USP publishes their standards in the United States Pharmacopeia-National Formulary (USP-NF).
The quality standards contained in USP–NF monographs apply to any articles that are marketed in the U.S. that are intended or labeled for use as drugs or as ingredients in drugs.
The USP Talc monograph contains requirements applicable to talc for pharmaceutical applications.
8
© 2019 USP
Background – FDA Interactions with USP
FDA-
Enforces USP standards for drug substances, drug products and excipients under the Federal Food, Drug, and Cosmetic Act.
– Note USP has no role in enforcement per USP General Notices 2.30 Legal Recognition.
Participates in USP’s standards-setting process and engages in research and development works.
Works with USP’s Expert Committees, workshops and stakeholder forums.
7
8
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
5
9
© 2019 USP
Overview – FDA request to USP Nov. 16, 2010
The FDA Monograph Modernization Task Group (MMTG) sent a letter to USP requesting USP to modernize the USP Talc monograph as a high priority.
10
© 2019 USP
Overview – FDA request to USP Nov. 16, 2010
The request for a revision was stated as follows:
–“Labeling should be revised to match the statements that are provided in the Talc FCC monograph, thereby assuring that Talc is not sourced from mines that are known to contain asbestos. Also, USP should consider revising the current tests for asbestos to ensure adequate specificity.”
9
10
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
6
11
© 2019 USP
Urgency to update USP Talc Monograph
FDA requested USP to modernize the Talc monograph for Asbestos testing and labeling as “high urgency” because:
– High impact on public health.
This effort reflects the resolutions adopted by USP in 2010 convention and re-affirmed in 2015 Convention. The Excipient’s Expert Committee included this revision in their work plan.
Part of the work plan of the Pharmacopeial Discussion Group (PDG), represented by USP, Ph. Eur. and JP.
12
© 2019 USP
Deficiency of the current Talc Monograph –Absence of Asbestos Test
Deficiency of the current test for “Absence of Asbestos”-
FibersPresent?
Light Microscopy (LM)
AsbestosPresent
No
Yes
AsbestosNot
Present
AsbestosNot
Present
Yes
either Infrared (IR)
Amphibole or SerpentineDetected?
No
or X-ray Diffraction (XRD)IR and XRD may haveFalse-Negative
LM may haveFalse-Positive
11
12
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
7
13
© 2019 USP
Deficiency of the current Talc Monograph –Absence of Asbestos Test
Analysts are given the option to perform:
- Procedure 1: infrared spectroscopy [Identification Tests–General <197>]
- OR - Procedure 2: x-ray diffraction
[Characterization of Crystalline and Partially Crystalline Solids by X-Ray Powder Diffraction (XRPD) <941>]
If either test gives a positive result, then
- Procedure 3: optical microscopy [Optical Microscopy <776>] must be performed to confirm.
14
© 2019 USP
Deficiency of the current Talc Monograph –Absence of Asbestos:SUMMARY
The infrared spectroscopy (IR) and x-ray diffraction (XRD) methods,
if used alone,
could lead to False-Negative results,
which could allow
talc samples with asbestos contamination
to pass
the Absence of Asbestos test
of
the current USP Talc monograph.
13
14
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
8
15
© 2019 USP
Deficiency of the current Talc Monograph –Absence of Asbestos: SUMMARY
After applying the current USP microscopy method,
the analyst cannot rule out
the presence of asbestos in the sample.
The lack of particulate/particle
identification procedures
in the optical microscopy section
could lead to
false results.
16
© 2019 USP
Deficiency of the current Talc Monograph –Absence of Asbestos
Talc Expert Panel #2 General Comments on Current Monograph Method
IR absorption spectroscopy and X-ray diffraction cannot distinguish asbestos (i.e., shapes) from non-asbestos forms of the same mineral. So, in case of positive answer by one of these methods, the morphology of the mineral should be examined using polarized light optical microscopy.
It is difficult to set the detection limit of this method since the Absence of Asbestos standard is dependent on the particle-size distribution of the pharmaceutical grade&Not all pharmaceutical grades share the same particle-size distribution.
15
16
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
9
17
© 2019 USP
Overview – USP Talc Expert Panels and published Stimuli Articles
Talc Expert Panel #1 (Cycle 2010-2015)
The Talc Expert Panel (EP #1) was formed to address the request submitted in a letter from the FDA MMTG (dated November 16, 2010) to modernize the high priority USP-NF Talc monograph.
The Talc EP#1 was charged with modernizing the USP Talc monograph to ensure that the tests contained in the Absence of Asbestos have adequate specificity.
18
© 2019 USP
Overview – USP Talc EP #1 and Stimuli #1
Talc Panel #1 Stimuli Paper
Pharmacopeial Forum (PF) 40(4) [Jul – Aug 2014]
Note Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts
available at: https://www.uspnf.com/pharmacopeial-forum
17
18
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
10
19
© 2019 USP
Overview – USP Talc EP #1 and Stimuli #1
The Expert Panel #1 recommendation for revision of the test for Absence of Asbestos included
omission of the infrared spectroscopy test &
inclusion of a revised x-ray diffraction procedure, in combination with one or more microscopic evaluations
polarized-light microscopy, transmission electron microscopy or scanning electron microscopy
Also recommended were additional sample preparation/concentration methods.
20
© 2019 USP
Talc EP #1 Recommendations on the Deficiencies
FibersPresent?
Light Microscopy (LM)
AsbestosPresent
No
Yes
AsbestosNot
Present
AsbestosNot
Present
Yes
either Infrared (IR)
Amphibole or SerpentineDetected?
No
or X-ray Diffraction (XRD) IR and XRD may haveFalse–NegativeEP#1 Recommendations:
1) Delete IR
2) Improve XRD
3) Combination with
one or more microscopic
evaluations
LM may haveFalse –Positive
19
20
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
11
21
© 2019 USP
FDA request (2010)
“Labeling should be revised to match the statements that are provided in the Talc FCC monograph, thereby assuring that Talc is not sourced from mines that are known to contain asbestos.
Description in the FCC Talc monograph:
“….Talc derived from deposits that are known to contain associated asbestos is not food grade. It is insoluble in water and in solutions of alkali hydroxides, but is slightly soluble in dilute mineral acids.”
Labeling – USP Talc Expert Panel #1 (Stimuli #1)
22
© 2019 USP
Labeling in the existing USP Talc monograph:
“The label states, where applicable, that the substance is suitable for oral or topical administration. The certificate of analysis states the absence of asbestos. It also indicates which method specified in the test for Absence of Asbestos was used for analysis.”
Stimuli article #1 (2014)“It is the conclusion of the Talc Expert Panel that mine suitability as a source of talc is not subject to USP quality standards. Rather, it is the responsibility of the talc supplier to supply a product that is asbestos free and can meet the USP compendial standards.
Based on the above, the panel #1 recommended updating statements in the definition and/or labeling sections to indicate that talc containing (detectable) asbestos is not pharmaceutical grade.
Labeling – USP Talc Expert Panel #1 (Stimuli #1)
21
22
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
12
23
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Talc Expert Panel #2 (Revision Cycle 2015-2020)
The 2010-2015 Excipient Monograph committee concluded that USP should create a Talc Methods Expert Panel to address the task of identifying appropriate analytical methods and Reference Standards (RS's) for testing Absence of Asbestos in Talc.
The new Expert Panel #2 would develop and optimize Talc analytical methods and develop RS based on knowledge gained from the Talc Expert Panel that will conclude at the end of the 2010-2015 Cycle.
EP #2 would also review, evaluate and generate proposals, procedures, and data to modernize of the test for asbestos, and will provide recommendations to the relevant Expert Committees.
24
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Key Tasks for Expert Panel #2 Derive a workable set of analytical procedures based on scientific principles that will satisfy the FDA request to USP to consider revising the current tests for asbestos to ensure adequate specificity & allow talc suppliers to strive to ensure that talc products used in medicines are not harmful to human health.
Recognize: state-of-art methodspracticality in industry population size detection limitquantificationprecision & accuracy
23
24
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
13
25
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Major Issues Facing Talc EP#2
1. Develop analytical procedures for industry that meet FDA and public confidence. Test methods should strike an appropriate balance between the need to address a significant quality issue and the industry’s ability to perform requisite testing.2. Remain neutral in health effects talc litigation. (Focus on Science)3. Focus on minerals with record of harmful health effects that could occur with talc ores.4. Clarify and standardize terminology.
26
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Issues Dealt with by Talc EP#2
Analytical Methods Protocols sample preparation and testing protocols Phased Testing Sequencing What analytes to test for?? What is Positive for Presence of Asbestos? What is Negative for Presence of Asbestos? Detection limits QA/QC Interpreting data Reporting results Round robin to test protocols Definitions/Nomenclature
25
26
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
14
27
© 2019 USP
Overview – USP Talc EP #2 Stimuli articles
Stimuli article #2:“USPC Responses to Comments on Stimuli Article “Modernization of Asbestos Testing in USP Talc”, PF 43(4) [Jul-Aug 2017].
Planning Stimuli article #3:“Modernization of Asbestos Testing in USP Talc - Part 2”, Targeting to publish in PF 46(5) [Sep-Oct 2020].
1. Introduction2. What particles to consider for the proposed revision3. X-Ray diffraction4. Polarized light microscopy5. Ambiguities and interferences, detection limits and
measurement uncertainty6. Conclusions and recommendations
28
© 2019 USP
“Asbestos” and Mineral Nomenclature
Many different definitionsof
asbestos,asbestiform,
fiber…
Word meanings can change with time!
27
28
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
15
29
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Scientifically rigorousConsistent with regulatory practices
Particle Identificationby
Chemical CompositionShape/MorphologyCrystal Structure
30
© 2019 USP
“transitional”
talc
fibroustalc
amphiboles asbestiform amphiboles
overgrowths
domains
How to treat
a mixed box?
“Talc” can be a complex mixture of minerals and morphologies
29
30
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
16
31
© 2019 USP
Talc, Asbestos,
Amphiboles&
Numerous Minerals
One can often find “something”
elongate in almost all rocks!
** Ref. - See Gunter et al, 2016Buzon & Gunter, 2016, esp. for sepiolite
32
© 2019 USP
SHAPE (“morphology” & aspect ratio)
chrysotile
The “easier” stuff, especially ACBM (building materials)
31
32
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
17
33
© 2019 USP
Modified from US Bureau of Mines Report No. IC 8751, “Selected Silicate Minerals and their Asbestiform Varieties”. Campbell, 1977
Aspect ratio most agree on!
Disagreement
ASPECT RATIO &
”Federal Fiber”PopulationHow many particulates to count to confirm a Positive?
“Federal Fiber”
Population number
ofparticles
34
© 2019 USP
The Big Issues
Measurement & regulation of “elongate”particles (EMP’s)
oftalc? tremolite? anthophyllite? chrysotile?
(& some other minerals, esp. sepiolite)
cleavage fragments(broken crystals)
acicular/prismatic shapes(long & narrow crystals & fragments)
asbestiform minerals(fibers formed by crystal growth)
“WE” PREFER NOT TO USE THE TERMSFibrous Talc
Asbestiform Talc
33
34
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
18
35
© 2019 USP
The Big Issues
Measurement & regulation of “elongate”particles (EMP’s)
TALC
“WE” PREFER NOT TO USE OR LIMIT USAGE of the
TERMSFibrous Talc
(use ribbon talc)
Asbestiform Talcgiven the possible confusion
with regulatory asbestos
36
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
Recommendations:Our “Dictionary”
Particle instead of particulate
Elongate rather than elongated
Change “Absence of Asbestos”
To“Test for Asbestos”
35
36
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
19
37
© 2019 USP
Overview – USP Talc EP #2 adopted the following definition
For the purposes of the USP “Absence of Asbestos”
[Test for Asbestos]” method,
The definition of asbestos will include the six regulated asbestos phases:serpentine (chrysotile) and five amphiboles (amosite, crocidolite, actinolite-asbestos, tremolite-asbestos, and anthophyllite-asbestos).
and in addition,
other asbestiform amphiboles with a focus on those known to cause asbestos-related disease.
38
© 2019 USP
Overview – USP Talc EP #2 adopted the following definition
EPA considered that “asbestiform” includes aspects of morphology visible in the polarizing light microscope and described it as follows: “Said of a mineral that is like asbestos, i.e., crystallized with the habit of asbestos. Some asbestiform minerals may lack the properties which make asbestos commercially valuable, such as long fiber length and high tensile strength. With the light microscope, the asbestiform habit is generally recognized by the following characteristics:Mean aspect ratios ranging from 20:1 to 100:1 or higher for fibers longer than 5 µm. Aspect ratios should be determined for fibers, not bundles.Very thin fibrils, usually less than 0.5 micrometers in width, andTwo or more of the following:
Parallel fibers occurring in bundles,Fiber bundles displaying splayed ends,Matted masses of individual fibers, and/orFibers showing curvature
U.S. Environmental Protection Agency. Test Method EPA/600/R-93/116, 1993, Method for the Determination of Asbestos in Bulk Building Materials. Perkins, R.L. and B. W. Harvey.
EPA-600/M4-82-020, 1982, Test Method- Interim Method for the determination of asbestos in bulk insulation samples. 12 pp
37
38
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
20
39
© 2019 USP
Identification IssuesSamplingTesting
Interpretation
40
© 2019 USP
Overview – USP Talc Methods Expert Panel (EP #2)
The ideal goal is to strive
dispassionately for
PROOF!
39
40
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
21
41
© 2019 USP
X-ray Diffraction (XRD) – Round robin 1 & 2 studies
– Three labs participated in the study within the Expert Panel.
– Focused on the instrument/experimental parameters and detection and resolution
– Results of the improved XRD method• detection and resolution of tremolite and anthophyllite at 0.25% and 1% levels
• detection of serpentine at 0.25% and 1% levels without chlorite interference• detection of serpentine at 1% level with 1% chlorite interference.
Round Robin Studies
42
© 2019 USP
Polarized Light Microscopy (PLM) – Round robin study
Five labs participated in the study within the Expert Panel.
Thirteen levels of samples used, including pure talc, spiked non-asbestos tremolite, chrysotile, tremolite-asbestos
at 1ppm, 10 ppm, 100 ppm and 1000 ppm analyte levels, respectively.
All labs successfully detected asbestos at the level of 100 ppm[0.01% (w/w) based on the spiked samples].
Asbestiform and non-asbestiform can be differentiated using PLM.
Round Robin Studies
41
42
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
22
43
© 2019 USP
YesYes
Concentration Method?
1. Evaluate the >5 um size fraction
Recommended Changes to USP Monograph:“Test for Asbestos”A Phased Approach
No
EM (SEM, TEM)
Amphibole/SerpentineDetected?
AsbestosDetected
(>0.01%)Yes Amphibole/
SerpentineAsbestos?
UnidentifiedSuspectFibers?
PLM
Wet Sieve Concentration
XRD Positive?
XRD Analysis
2. Evaluate the <5 um size fraction(Pending Phase II Evaluation)
No
No
Phase I Phase II Proposal
Report AsbestosContent
(Empirical DetectionLimit To be
Determined)
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
XRD Negative?
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
PLM
Wet Sieve Concentration
No
Yes
44
© 2019 USP
Definition of asbestos will include the six regulated asbestos phases, which include one serpentine (chrysotile) and five amphiboles (amosite, crocidolite, actinolite-asbestos, tremolite-asbestos, and anthophyllite-asbestos). & other asbestiform amphiboles with a focus on those known to cause asbestos-related disease.
Conclusions and Recommendations of EP #2
43
44
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
23
45
© 2019 USP
Methodology – Phased approach Phase I: XRD and PLM (mandatory) – supported by successful round robin studiesPhase II: evaluate electron microscopy methods, such as TEM (with EDS and SAED), and SEM, etc., considering round robin studies.
Conclusions and Recommendations of EP #2
46
© 2019 USP
Reporting “Pass/Fail”, focusing on the six regulated asbestos phases, but also asbestiform amphiboles known to cause asbestos-related disease.
Recommends changing the name of the USP Talc monograph test from
“Absence of Asbestos” to “Test for Asbestos”
Conclusions and Recommendations of EP #2
45
46
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
24
47
48
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
25
Phone | Social Media | Email
49
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
1
USP Talc Methods Expert Panel Update- X-Ray Diffraction
Gary TomainoMember, Talc Methods Expert PanelMarch 13, 2020
1
2
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
2
3
© 2019 USP
Disclaimer
This presentation reflects the current work and recommendations of the USP Talc Expert Panels.
The content and views expressed do not necessarily reflect the policies of the U.S. Pharmacopeial Convention or the USP Council of Experts.
4
© 2019 USP
Outline
4
© 2019 USP
ore TALC powder
SEM image TALC
chrysotile
“pharma”
X-Ray DIFFRACTION (XRD)
- XRD Overview
- Talc Expert Panel #1 RECOMMENDATIONS
- Talc Methods Expert Panel #2 OBJECTIVES
XRD ROUND ROBIN (RR) STUDIES
- XRD RR #1
- XRD RR #2- Confirmation of initial blending- Examples of participating labs- Examples of quantification
- General findings/ Findings of RR #1 and 2
XRD ROUND ROBIN # 3 (Future study recommendation)
3
4
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
3
5
© 2019 USP
1) primary analysis technique and an important tool for any mineral and material characterizations qualitatively and when applicable quantitatively to the method
2) critical to identification of phases present in the talc product
3) determine overall purity of a talc product and its accessory minerals, that ensures compliance with the USP Talc monograph.
4) applied to end consumer product can provide identification of other mineral additives to a formulation and provide an alert to laboratory as to some unknown adulteration
5) provide qualitatively and quantitatively, total amphibole and total serpentine of talc product, end use product
6) cannot distinguish morphology and therefore cannot be used to exclusively determine presence of asbestiform amphibole or asbestiform serpentine; as noted used in conjunction with another microscopy method.
X-Ray Diffraction (XRD) OVERVIEW
6
© 2019 USP
TALC EXPERT PANEL (EP) #1 RECOMMENDATIONS
The infrared (IR) spectroscopy test for absence of asbestos should be omitted in favor of XRD.
Any “stopping rule” following an XRD evaluation and determination of no detectable amphibole or serpentine would not be acceptable and was deficient in the characterization of a talc product.
AND
At least one or more microscopy techniques (PLM or TEM-EDS-SAED or SEM-EDS) is necessary to provide specificity to the attribute modifications.
5
6
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
4
7
© 2019 USP
Procedure 2 (XRD) limited evaluation conditions: amphibole and serpentine.
Amphibole diagnostic diffraction peak at ~10.50 2θ was noted for tremolite however the amphibole diagnostic peak for anthophyllite at ~10.70 2θ was not considered (Cu radiation).
Partial or full overlap of chlorite group minerals with serpentine minerals was not addressed within the confines of the two specific serpentine scan regions
higher detection limits for serpentine leading to false-positives for serpentine
A given analyst/laboratory should understand that XRD provides total amphibole ortotal serpentine content and does not distinguish the morphology of asbestiform and non-asbestiform amphiboles or serpentine
TALC EP #1 RECOMMENDATIONS for XRD
8
© 2019 USP
ROUND ROBIN #1
INSTRUMENT AND SAMPLE ALIGNMENT, MINERALOGICAL IDENTIFICATION
PRIMARY NIST REFERENCE(S), SECONDARY TALC REFERENCE MATERIAL (NOT PHARMA-TALC)
ROUND ROBIN #2
RESOLUTION TESTS AND RELATIVE DETECTION LIMITS
TREMOLITE versus ANTHOPHYLLITE
SERPENTINE versus CHLORITE
ROUND ROBIN # 3 (Recommend for future study)
LIMIT OF QUANTIFICATION AND LIMIT OF DETECTION (BELOW 0.25%)
TREMOLITE versus ANTHOPHYLLITE
SERPENTINE versus CHLORITE
TALC EP #2 XRD Round Robin Objectives
7
8
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
5
9
© 2019 USP
XRD ROUND ROBIN STUDIES
XRD Round Robin #1
10
© 2019 USP
1) general instrument and full 2θ scan conditions at a minimum over the range 4-55 or higher 2θ (minimum)
2) instrument and sample alignment checks for achieving and for providing a qualitative mineralogical profile including identification of amphibole and serpentine in addition to other minerals present
chlorite, carbonates (magnesite, calcite, dolomite), quartz, feldspars, apatite
provides user on the purity of the talc
Recommendations to incorporate calibration standards and reference materials as routine part of the lab procedures
TALC EP #2 XRD ROUND ROBIN #1
9
10
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
6
11
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #1
NIST STANDARDS RECOMMENDED (one or more) PRIMARY CRM SPECIFIC TO XRD
INSTRUMENT ALIGNMENT PRECISION
1976----------Alumina plate---Instrument Sensitivity Standard for XRD
660a---------LaB6, line position/line profile standard for XRD
640B/C/D/E--------- Si metal, line position/line profile standard for XRD
SAMPLE ALIGNMENT PRECISION PACKING TECHNIQUE
675---------Low 2 theta (large d-spacing) for XRD; Fluorophlogopite
640B/C--------- Si metal, line position/line profile standard for XRD
ANALYST COMPETENCY FOR SAMPLE PACKING ALIGNMENT
674b--------Intensity Set* for XRD; TiO2, ZnO, Cr2O3, CeO2;
*peak position two-theta tables for each phase
12
© 2019 USP
ISO 17025 QUALITY PROGRAM-COMPETENCY ANALYST NIST 640C SILICON POWDER
NIST VALUES d-Spacing
AN
ALY
ST
VA
LU
ES
11
12
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
7
13
© 2019 USP
ADDITIONAL Reference Materials (TALC)
PRIMARY REFERENCE MATERIALS--BRAMMER CERTIFIED REFERENCE
JAPANESE CERAMIC RM 901, 902, 903
[PURCHASED AS A SET OF 3]50 grams each; $1250/set
SECONDARY REFERENCE MATERIAL--BRAMMER CERTIFIED REFERENCE
BCS 203a RM
RM 100 grams; $255(TOMAINO TO PROVIDE TO SUB-GROUP USP/ASTM)
IN-HOUSE TALC REFERENCES (PHARM-PRODUCTS)
14
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #1
QUALITATIVE SCAN
TALC MAJOR
CHLORITE TRACE
QUARTZ TRACE
DOLOMITE TRACE
MAGNESITE MINOR
13
14
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
8
15
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #1
16
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #1
9.3559.335 9.347 9.339
9.150
9.200
9.250
9.300
9.350
9.400
9.450
9.500
9.550
1 2 3 4
d-S
PA
CIN
G (
AN
GS
TR
OM
)
REPLICATE RUN
TALC SAMPLE ALIGNMENT-IDENTIFICATION
15
16
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
9
17
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #1
3.118
3.1163.117
3.116
3.110
3.112
3.114
3.116
3.118
3.120
3.122
3.124
3.126
3.128
3.130
1 4
d-S
PA
CIN
G (
AN
GS
TR
OM
)
REPLICATE RUN
TALC SAMPLE ALIGNMENT-IDENTIFICATION
PDF 19-7703.12 +/-0.01
18
© 2019 USP
XRD ROUND ROBIN STUDIES
XRD Round Robin #2
17
18
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
10
19
© 2019 USP
1) GENERAL INSTRUMENT and QUANTITATIVE 2θ scan conditions
TREMOLITE, ANTHOPHYLLITE, SERPENTINE, CHLORITE
2) RESOLUTION and DETECTION of TREMOLITE and ANTHOPHYLLITE
0.25% and 1% levels
3) RESOLUTION and DETECTION of SERPENTINE without CHLORITE INTERFERENCE
0.25% and 1% levels
4) RESOLUTION and DETECTION of SERPENTINE with CHLORITE INTERFERENCE
1% Serpentine/1% Chlorite levels
TALC EP #2 XRD ROUND ROBIN #2
20
© 2019 USP
RESOLUTION and RELATIVE DETECTION LIMIT IN TALC
1% TREMOLITE-NA 1% ANTHOPHYLLITE-A (A-181; AS RECEIVED) 1% SERPENTINE/CHRYSOTILE (#1422 WCD, AS RECEIVED)
0.25% TREMOLITE-NA 0.25% ANTHOPHYLLITE-A (A-181; AS RECEIVED) 0.25% SERPENTINE/CHRYSOTILE (#1422 WCD, AS RECEIVED)
1% Serpentine/Chrysotile (#1422 WCD, AS RECEIVED)1% Chlorite (highly crystalline spike-fine powder)
BASE LINE TALC [NO CHLORITE, CARBONATES; MACRO-CRYSTALLINE FORM]
TALC EP #2 XRD ROUND ROBIN #2
19
20
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
11
21
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
3) TREMOLITE AND ANTHOPHYLLITE START ANGLE (2-THETA): RECOMMENDED 9.8
END ANGLE (2-THETA): RECOMMENDED 11.2
STEP-SIZE (2-THETA): RECOMMENDED 0.02
COUNT TIME/STEP RECOMMENDED SECONDS 100
4) ANTHOPHYLLITE START ANGLE (2-THETA): RECOMMENDED 28.8
END ANGLE (2-THETA): RECOMMENDED 29.8
STEP-SIZE (2-THETA): RECOMMENDED 0.02
COUNT TIME/STEP RECOMMENDED SECONDS 100
5) SERPENTINE AND CHLORITE START ANGLE (2-THETA): RECOMMENDED 11
END ANGLE (2-THETA): RECOMMENDED 13.2
STEP-SIZE (2-THETA): RECOMMENDED 0.02
COUNT TIME/STEP RECOMMENDED SECONDS 100
6) SERPENTINE AND CHLORITE START ANGLE (2-THETA): RECOMMENDED 23.5
END ANGLE (2-THETA): RECOMMENDED 25.6
STEP-SIZE (2-THETA): RECOMMENDED 0.02
COUNT TIME/STEP RECOMMENDED SECONDS 100
QUANTITATIVE
SCAN
CONDITIONS
22
© 2019 USP
CONFIRMATION OF INITIAL BLENDING (RR #2)
TALC EP #2 XRD ROUND ROBIN #2
21
22
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
12
23
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
QUALITATIVE SCAN CONDITIONS
1% TREMOLITE
1% ANTHOPHYLLITE
1% SERPENTINE
24
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
QUANTITATIVE SCAN CONDITIONS
1% TREMOLITE
1% ANTHOPHYLLITE
1% SERPENTINE
23
24
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
13
25
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
CONE AND QUARTER, GRAB TESTING
GOOD REPLICATION OF THE BLENDS
RE-COMBINE, MIX, SUB-SAMPLE
26
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
CONE AND QUARTER, GRAB TESTING
GOOD REPLICATION OF THE BLENDS
RE-COMBINE, MIX, SUB-SAMPLE
25
26
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
14
27
© 2019 USP
CONFIRMATION OF FINAL BLENDING ROUND ROBIN #2
TEN (10) REPLICATE SUB-SAMPLES TAKEN
1% TREMOLITE-ANTHOPHYLLITE-SERPENTINE
0.25% TREMOLITE-ANTHOPHYLLITE-SERPENTINE
SEVEN (7) REPLICATE SUB-SAMPLES TAKEN
1% SERPENTINE WITH 1% CHLORITE INTERFERENCE
TALC EP #2 XRD ROUND ROBIN #2
28
© 2019 USP
REPLICATE OVERLAY
BASELINE
0.25% T-A-S
1% T-A-S
TALC EP #2 XRD ROUND ROBIN #2
27
28
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
15
29
© 2019 USP
10 REPLICATES OVERLAY
0.25% T-A-S
TREMOLITE -ANTHOPHYLLITE
TALC EP #2 XRD ROUND ROBIN #2
30
© 2019 USP
10 REPLICATES OVERLAY
0.25% T-A-S
SERPENTINE
TALC EP #2 XRD ROUND ROBIN #2
29
30
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
16
31
© 2019 USP
7 REPLICATES OVERLAY
1% SERPENTINE
1% CHLORITE
TALC EP #2 XRD ROUND ROBIN #2
32
© 2019 USP
EXAMPLES OF
PARTICIPATING LABS
TALC EP #2 XRD ROUND ROBIN #2
31
32
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
17
33
© 2019 USP
0.25% T-A-SLAB RR#2
TALC EP #2 XRD ROUND ROBIN #2
34
© 2019 USP
1% T-A-SLAB RR#2
TALC EP #2 XRD ROUND ROBIN #2
33
34
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
18
35
© 2019 USP
1% SERPENTINE1% CHLORITELAB RR#2
TALC EP #2 XRD ROUND ROBIN #2
36
© 2019 USP
EXAMPLES OF
QUANTIFICATION
TALC EP #2 XRD ROUND ROBIN #2
35
36
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
19
37
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
EXAMPLES OF QUANTIFICATION 1% TREMOLITE 1% ANTHOPHYLLITE
38
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
EXAMPLES OF QUANTIFICATION 0.25% TREMOLITE 0.25% ANTHOPHYLLITE
37
38
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
20
39
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
EXAMPLES OF QUANTIFICATION PEAK HEIGHT 1% AND 0.25% T-A
40
© 2019 USP
TALC EP #2 XRD ROUND ROBIN #2
EXAMPLES OF QUANTIFICATION PEAK AREA 1% AND 0.25% T-A
39
40
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
21
41
© 2019 USP
XRD ROUND ROBIN STUDIES
XRD Round Robin Findings
42
© 2019 USP
TALC EP #2 XRD ROUND ROBIN 1 and 2
GENERAL FINDINGS:
XRD Round Robin 1 and 2
1) provide the analyst-laboratory with the ability to identify and if needed quantify for total amphibole and total serpentine in a pharmaceutical talc product.
2) microscopic technique(s) utilized following the XRD evaluation should correlate/trend with relative levels of amphibole or serpentine, if detected
3) microscopic technique(s) should not find and should not state amphibole or serpentine levels at substantially higher than the XRD level
41
42
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
22
43
© 2019 USP
FINDINGS:
XRD Round Robin 1 and 2
1) acceptable resolution and detection of tremolite and anthophyllite at 0.25%
2) easily resolved and detected tremolite and anthophyllite at 1%
3) acceptable detection of serpentine at 0.25% without chlorite interference
4) easily detected serpentine at 1% without chlorite interference
5) acceptable resolution and detection of serpentine at 1% with chlorite at 1%
TALC EP #2 XRD ROUND ROBIN 1 and 2
44
© 2019 USP
REPORTING LEVELS BASED ON RR#2
For the data thus far collected in the round robin, it is recommended the XRD portion of the asbestos attribute state:
1) if no detectable peak for tremolite or anthophyllite then “none detected < 0.2%”
2) if no detectable peak for serpentine without chlorite interference then “none detected < 0.2%”
3) if no detectable peak for serpentine with 1% chlorite interference then “none detected < 0.5%”
note: chlorite levels above 1% up to 10-15% would increase the detection limit of serpentine to 1%
TALC EP #2 XRD ROUND ROBIN 2
43
44
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
23
45
© 2019 USP
RECOMMENDATIONS TALC EP#2
While the XRD round robin study used samples prepared with known amphibole and serpentine amounts to determine a relative limit of detection for XRD:
It would be the analyst or laboratory’s responsibility to perform the confirmation of a properly calibrated instrument and confirmation of the XRD evaluation on a set of talc reference materials
Compliance with the compendia standard for the mandatory XRD reporting:
need only be a Pass-Fail result-limit and not a quantitative result
TALC EP #2 XRD ROUND ROBIN 2
46
© 2019 USP
TALC EP #2 Recommendation on XRD ROUND ROBIN #3
1) Round Robin 3 be conducted to confirm if amphibole levels should be set at 0.1%.2) However, each laboratory performing the test would need to verify individual
detection limits.
0.5% TREMOLITE-NA 0.5% ANTHOPHYLLITE-A (A-181; MILLED) 0.5% SERPENTINE/CHRYSOTILE (#1422 WCD, AS RECEIVED)
0.25% TREMOLITE-NA 0.25% ANTHOPHYLLITE-A (A-181; MILLED) 0.25% SERPENTINE/CHRYSOTILE (#1422 WCD, AS RECEIVED)
0.1% TREMOLITE-NA 0.1% ANTHOPHYLLITE-A (A-181; MILLED) 0.1% SERPENTINE/CHRYSOTILE (#1422 WCD, AS RECEIVED)
BASE LINE TALC(s) [TO BE DETERMINED]
45
46
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
24
47
© 2019 USP
QUANTITATIVE ANALYSES METHOD OF ADDITIONS ASTM TALC
QUANTITATIVE
SCAN
0.16% TREMOLITE
ADDITION
48
© 2019 USP
QUANTITATIVE ANALYSES METHOD OF ADDITIONS ASTM TALC
QUANTITATIVE
SCAN
0.16% TREMOLITE
ADDITION
47
48
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
25
49
50
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
26
Phone | Social Media | Email
51
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
1
USP Talc Monograph Update – Polarized Light Microscopy
Julie PierCo-chair, Talc Methods Expert PanelMarch 13, 2020
1
2
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
2
3
© 2019 USP
Disclaimer
This presentation reflects the current work and recommendations of the USP Talc Expert Panels.
The content and views expressed do not necessarily reflect the policies of the U.S. Pharmacopeial Convention or the USP Council of Experts.
4
© 2019 USP
Agenda – USP Talc Monograph UpdatePolarizing Light Microscopy (PLM)
Phased Approach
– What Phase I tells us
– Example
PLM Methodology
– What PLM tells us
– Conducting the Round Robin
– Results/Conclusions
– Creation of spiked materials for study
Next steps
– Phase II methods validation
– Things to consider/Discussion
4
© 2019 USP
3
4
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
3
5
© 2019 USP
YesYes
Concentration Method?
1. Evaluate the >5 µm size fraction
Recommended Changes to USP Monograph:“Test for Asbestos”Phased Approach
No
EM (SEM, TEM)
Amphibole/SerpentineDetected?
AsbestosDetected(>0.01%)
Yes Amphibole/SerpentineAsbestos?
UnidentifiedSuspectFibers?
PLM
Wet Sieve Concentration
XRD Positive?
XRD Analysis
2. Evaluate the finer size fraction(Pending Phase II Evaluation)
No
No
Phase I Phase II Proposal
Report AsbestosContent
(Empirical DetectionLimit To be
Determined)
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
XRD Negative?
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
PLM
Wet Sieve Concentration
No
Yes
6
© 2019 USP
Phased Approach
As no one method gives the complete picture, the phased approach proposes complementary methodology to evaluate the full particle size spectrum:
– Larger (>5 µm) size fraction/Phase I (XRD/PLM)
– Smaller size fraction (not resolved by PLM)/Phase II (SEM/TEM)
Why start with Phase I?
– The phased approach builds on the original USP Monograph protocol (with recommended improvements and determination of an empirical detection limit).
– Asbestos, if present, should present itself over the full particle size distribution of a ground mineral mixture (see example).
– The larger particles of asbestos are easier to identify and characterize as asbestos as they display characteristic attributes.
5
6
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
4
7
© 2019 USP
Particle Size Distribution of Talc Products
0
2
4
6
8
10
12
0.1 1 10 100
Vo
lum
e %
Particle Size (um)
TEM
Roller Milled Product (Cosmetic size)Median Particle Size = 12 um
"AFG" Product(Alpine Fine Grind)Median Particle Size = 5 um
Light Microscopy (PLM)
8
© 2019 USP
Particle Size Distribution of Talc Products
0
2
4
6
8
10
12
0.1 1 10 100
Vo
lum
e %
Particle Size (um)
TEM
Roller Milled Product (Cosmetic size)Median Particle Size = 12 um
"AFG" Product(Alpine Fine Grind)Median Particle Size = 5 um
Light Microscopy (PLM)
Unlikely that asbestos would only be here:
7
8
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
5
9
© 2019 USP
Particle Size Distribution of Talc Products
0
2
4
6
8
10
12
0.1 1 10 100
Vo
lum
e %
Particle Size (um)
TEM
Roller Milled Product (Cosmetic size)Median Particle Size = 12 um
"AFG" Product(Alpine Fine Grind)Median Particle Size = 5 um
Light Microscopy (PLM)
More likely that asbestos would cover the full range:
10
© 2019 USP
Asbestos, if present, tends to concentrate in the larger size range of a talc/asbestos mixture.
– Asbestos resists grinding due to its high tensile strength and flexibility.
– Talc is easy to grind (softest mineral known)
– Amphibole and serpentine have higher hardness values than talc (4 – 6 vs. 1).
– Differential grinding profile causes preferential enrichment toward the larger sizes.
Years ago, grinding (to get rid of non-asbestos particles) and sieving (to concentrate asbestos) was the purification process for commercially produced asbestos.
Conclusion: if talc and asbestos are milled together, talc gets smaller while asbestos holds its strength. Therefore, it is very unlikely that asbestos would only be in the smallest size fraction of a ground talc/asbestos mixture.
Rather, the opposite is true.
Particle Size Distribution of Asbestos
9
10
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
6
11
© 2019 USP
Example:
Ground sample had a median particle size of 1-2 um– Finer than pharma and cosmetic talc.
– Likely contained both an asbestos and a non-asbestos component (as it was not a commercial asbestos product).
Suspect particles were identified by:1. Wet sieve isolation of the larger particles (+400 mesh = 38 um)
2. Analysis by XRD, PLM, and SEM
3. A separate (on-concentrated) sample was analyzed by TEM.
Conclusions:1. Asbestos/amphibole was present in all size fractions.
2. The asbestos component was more readily identified by PLM/SEM.
A finely ground “natural” talc ore sample with a trace level of amphibole asbestos(i.e. not spiked)
12
© 2019 USP
Example: XRD
Amphibole*
Talc Quantitative XRD scan
*Detected by quantitative scan only
11
12
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
7
13
© 2019 USP
Example: PLM (material retained on the sieve)
14
© 2019 USP
Example: SEM (material retained on the sieve)
400 X
1000 X
=TEM FOV
=TEM FOV
13
14
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
8
15
© 2019 USP
Example: TEM
*Analysis performed at 20,000X magnification
16
© 2019 USP
Existing StandardsPLM Asbestos Analysis in Bulk Materials
Bulk Building Materials– EPA 600/M4-82-020 (1982) and 600/R-93/116 (1993)
– NIOSH 9002
– OSHA ID191
– NY ELAP 198.1 and 198.6
Bulk Minerals– ISO 22262-1, A22262-2
– ASTM Draft (Work Item WK30024523)
– CTFA J4-1
– USP (Current Monograph) – LM only
15
16
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
9
17
© 2019 USP
Recommendations for PLM
Phase I recommendations:
– Drop FTIR
– Require microscopy (not conditional)
– Upgrade LM to PLM
– Investigate sieve concentration preparation
– Establish detection level
FibersPresent?
Light Microscopy
AsbestosPresent
No
Yes
AsbestosNot
Present
AsbestosNot
Present
Yes
XRD Analysis
Amphibole or SerpentineDetected?
No
FTIR Analysis - Or -
Existing Talc Monograph Procedure:
18
© 2019 USP
Amphibole Asbestos Analysis by PLM
Refractive index liquid of 1.605 used for screening.
Dispersion staining technique:– Amphibole = yellow/magenta– Talc = pale blue
Refractive index > liquid confirmed by Becke line.
Conclusive ID can be accomplished by use of additional RI liquids (if necessary).
Amphibole asbestos spiked into talc
17
18
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
10
19
© 2019 USP
Chrysotile (Asbestos) Analysis by PLM
Refractive index liquid of 1.55 used for screening
Dispersion staining technique:– Chrysotile = blue/magenta– Talc = pale yellow
Refractive index ≈ liquid confirmed by relief.
Original hypothesis (that PLM would be difficult for chrysotile) was proven to be incorrect.
Chrysotile (asbestos) spiked into talc
20
© 2019 USP
Wet sieving isolates the larger size range
– Capturing the larger particles (i.e. >400 Mesh), to concentrates all harder-to-grind materials (i.e. quartz, mica, asbestos – if present).
– Removes interfering small particles
This technique capitalizes on known asbestos attributes to assist in the analysis (labs participating in the Round Robin found this technique helpful).
Identification is easier because the larger particles more readily show observable attributes of asbestos.
The smaller size fraction can sometimes be ambiguous.
Wet Sieve Concentration Option Mandatory
19
20
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
11
21
© 2019 USP
Polarizing Light Microscopy (PLM)
0.001% (10 ppm) Chrysotile Spiked in Talc 0.001% (10 ppm) Tremolite Asbestos Spiked in Talc
PLM Advantage is morphology characterization
Observable asbestiform morphology preserved, even though aggressively ground and present at trace levels.
22
© 2019 USP
EPA Definition of “Asbestiform”(i.e. how to recognize it in an optical microscope)
From EPA 600/R-93/116 (similar to ISO 22262-1):
Mean aspect ratios ranging from 20:1 to 100:1 or higher for fibers longer than 5 µm. Aspect ratios should be determined for fibers, not bundles.
Very thin fibrils, usually less than 0.5 micrometers in width, and
Two or more of the following:– Parallel fibers occurring in bundles,*– Fiber bundles displaying splayed ends,*– Matted masses of individual fibers, and/or– Fibers showing curvature*
These characteristics refer to the population of fibers as observed in a bulk sample. It is not unusual to observe occasional particles having aspect ratios of 10:1 or less, but it is unlikely that the asbestos component(s) would be dominated by particles (individual fibers) having aspect ratios of <20:1 for fibers longer than 5 µm. If a sample contains a fibrous component of which most of the fibers have aspect ratios of <20:1 and that do not display the additional asbestiform characteristics, by definition the component should not be considered asbestos.
0.001% (10 ppm) Tremolite Asbestos spiked into talc
*Features observed in particles from the Round Robin study, even at trace levels.
21
22
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
12
23
© 2019 USP
Spiked Samples
TremoliteAsbestos
ChrysotileAsbestos
Tremolite(Non-Asbestiform)
0% (Un-spiked Talc)
0.0001% (1 ppm) 0.0001% (1 ppm) 0.0001% (1 ppm)
0.001% (10 ppm) 0.001% (10 ppm) 0.001% (10 ppm)
0.01% (100 ppm) 0.01% (100 ppm) 0.01% (100 ppm)
0.1% (1000 ppm) 0.1% (1000 ppm) 0.1% (1000 ppm)
• 13 samples per set• 8 sets created (including a reference set)• 104 samples total• Many hours contributed by Expert Panel #2 members
24
© 2019 USP
PLM Round Robin Results – Non-spiked Talc
No false positives in the non-spiked talc sample
Spike Level Lab Vial Asbestos Detected (Yes/No)
Asbestos Mineral Found
Amount Found
Non-spikedTalc
D D-11 No --- ---
E E-12 No --- ---
F F-5 No --- ---
G G-9 No --- ---
H H-11 No --- ---
23
24
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
13
25
© 2019 USP
PLM Round Robin Results – Tremolite Asbestos
One lab detected 0.001%
Four labs detected 0.01%
All labs detected 0.1%
One lab identified anthophyllite asbestos (test will not require amphibole speciation)
Amount not consistent (test will be positive/negative)
One false positive for chrysotile (single particle = contamination?)
Spike Level Lab VialAsbestos Detected?
Asbestos Mineral Amount
0.0001%Tremolite Asbestos
(1 ppm)
D D‐6 No ‐‐‐ ‐‐‐
E E‐11 No ‐‐‐ ‐‐‐
F F‐13 No ‐‐‐ ‐‐‐
G G‐1 No ‐‐‐ ‐‐‐
H H‐7 No ‐‐‐ ‐‐‐
0.001%Tremolite Asbestos
(10 ppm)
D D‐4 Yes Tremolite asbestos 0.0011
E E‐6 No ‐‐‐ ‐‐‐
F F‐10 No ‐‐‐ ‐‐‐
G G‐8 No ‐‐‐ ‐‐‐
H H‐1 No ‐‐‐ ‐‐‐
0.01%Tremolite Asbestos
(100 ppm)
D D‐12 Yes Tremolite asbestos 0.0013
E E‐13 Yes Tremolite asbestos 0.02
F F‐3 Yes Tremolite asbestos 0.002
G G‐12 No ‐‐‐ ‐‐‐
H H‐3 YesAnthophyllite asbestos
Chrysotile (1)0.03549
0.1%Tremolite Asbestos
(1000 ppm)
D D‐8 Yes Tremolite asbestos 0.003
E E‐8 Yes Tremolite asbestos 0.40
F F‐6 Yes Tremolite asbestos 0.019
G G‐11 Yes Tremolite asbestos 0.00893
H H‐9 Yes Anthophyllite asbestos 0.00130
26
© 2019 USP
PLM Round Robin Results – Chrysotile
One lab detected 0.0001%
Two labs detected 0.001%
All labs detected 0.01% and 0.1%
Amount not consistent (test will be positive/negative)
Consistent chrysotile detection by PLM unexpected
Spike Level Lab Vial Asbestos Detected?
Asbestos Mineral
Amount
0.0001% Chrysotile(1 ppm)
D D‐10 No ‐‐‐ ‐‐‐
E E‐9 No ‐‐‐ ‐‐‐
F F‐4 No ‐‐‐ ‐‐‐
G G‐4 No ‐‐‐ ‐‐‐
H H‐2 Yes Chrysotile 0.00190
0.001%Chrysotile(10 ppm)
D D‐7 Yes Chrysotile 0.0007
E E‐5 No ‐‐‐ ‐‐‐
F F‐9 No ‐‐‐ ‐‐‐
G G‐13 Yes Chrysotile 0.03015
H H‐6 No ‐‐‐ ‐‐‐
0.01%Chrysotile(100 ppm)
D D‐2 Yes Chrysotile 0.0028
E E‐1 Yes Chrysotile 0.02
F F‐1 Yes Chrysotile 0.029
G G‐2 Yes Chrysotile 1.2169
H H‐13 Yes Chrysotile 0.04584
0.1%Chrysotile(1000 ppm)
D D‐3 Yes Chrysotile Quant. not attempted
E E‐3 Yes Chrysotile 0.33
F F‐2 Yes Chrysotile 0.238
G G‐5 Yes Chrysotile 0.10653
H H‐10 Yes Chrysotile 0.05830
25
26
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
14
27
© 2019 USP
PLM Round Robin Results – Non-asbestiform Tremolite
Differentiation between non-asbestos tremoliteand tremoliteasbestos is achievable by PLM.
One false “positive” (chrysotile single particle = contamination?).
Spike Level Lab Vial Asbestos Detected?
Asbestos Mineral
Amount
0.0001%Non‐asbestiform Tremolite
(1 ppm)
D D‐5 No ‐‐‐ ‐‐‐
E E‐2 No ‐‐‐ ‐‐‐
F F‐12 No ‐‐‐ ‐‐‐
G G‐6 No ‐‐‐ ‐‐‐
H H‐8 No ‐‐‐ ‐‐‐
0.001%Non‐asbestiform Tremolite
(10 ppm)
D D‐1 No ‐‐‐ ‐‐‐
E E‐10 No ‐‐‐ ‐‐‐
F F‐11 No ‐‐‐ ‐‐‐
G G‐10 No ‐‐‐ ‐‐‐
H H‐4 No ‐‐‐ ‐‐‐
0.01%Non‐asbestiform Tremolite
(100 ppm)
D D‐9 No ‐‐‐ ‐‐‐
E E‐4 No ‐‐‐ ‐‐‐
F F‐7 No ‐‐‐ ‐‐‐
G G‐7 No ‐‐‐ ‐‐‐
H H‐12 No ‐‐‐ ‐‐‐
0.1%Non‐asbestiform Tremolite
(1000 ppm)
D D‐13 No ‐‐‐ ‐‐‐
E E‐7 No ‐‐‐ ‐‐‐
F F‐8 No ‐‐‐ ‐‐‐
G G‐3 No ‐‐‐ ‐‐‐
H H‐5 Yes Chrysotile (1) 0.00074
28
© 2019 USP
Results/Observations
Particles showed classic asbestiform morphology attributes (bundles, splayed ends, flexibility), even though aggressively ground to product size specifications.
No false positives in talc-only samples.
No false positives in non-asbestiform tremolite spikes.
False negatives for 1 ppm, and some 10 ppm samples (perhaps due to ability to create homogenous standards – or – limitation of method).
27
28
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
15
29
© 2019 USP
Method Limiting Observations
Two cases of single particle chrysotile detected in non-chrysotile sample (contamination?).
Anthophyllite vs. tremolite identification
– Tremolite asbestos has anomalous parallel extinction (could be confused with anthyphyllite?)
– Refractive indices overlap in some amphibole species
Concentrations were not consistent.
30
© 2019 USP
Conclusions/Summary
Working detection level will be 0.01% (100 ppm).
Result will remain positive/negative (vs. a quantified result).
Sieve prep step will be mandatory.
Minimum of 5 microscope slide preps will be required (or minimum weight).
Speciation of amphiboles will not be required.
A single particle is not distinguishable from background/contamination.
29
30
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
16
31
© 2019 USP
Challenges with Creating Spikes for Round Robin
Asbestos does not behave as a typical analyte.
Dispersion of asbestos (fiber) into matrix talc (powder) is difficult.
Particle size distribution is different between talc and asbestos.
Talc and asbestos have differential grinding profiles.
Tremolite Asbestos:
32
© 2019 USP
Procedure for Creating Spikes for Round Robin Study
Start with talc “chips” (unground raw ore provided by one talc supplier).
Mix a known amount of analyte (chrysotile, tremolite asbestos, and non-asbestiform tremolite) to produce a stock mixture (i.e. 1%).
Aggressively co-mill stock talc + analyte to reach typical talc product specification.
Dilute to desired concentration using a mixture of various talc raw materials provided by FDA. FDA received these raw material samples from talc suppliers as part of survey conducted in 2010.
Mix diluted samples to thoroughly disperse the stock mixture.
Result: simulated talc product with trace levels of asbestos (NOT simply adding commercial grade asbestos to already ground talc powder).
31
32
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
17
33
© 2019 USP
Mixture of talc for dilution
2010 FDA Talc Survey (https://www.fda.gov/media/122418/download)
– Included 27 raw material talc samples from various suppliers.
– Both major US talc suppliers were represented.
– All samples tested negative for asbestos by PLM and TEM* applying a gravimetric reduction method to prepare 3 specimens of each sample.
A mixture of various talc products from several suppliers participating in this survey were used to dilute the spiked base material (talc + analyte) to various concentrations.
Using this material, samples could not be traced to any one supplier.
*See e.g. NY ELAP 198.4; TEM average limit of detection quoted as 0.021 ppm ± 0.001.
34
© 2019 USP
Crushed Talc + 100 ppm amphibole asbestos
Approach: Co-milling Asbestos and Crushed Talc Base Material
~100% recovery
McCrone® Micronizing Mill
33
34
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
18
35
© 2019 USP
Analyte spiked into Talc Base Material @1%:- Homogeneity checked on 3 replicates using XRD
0
5000
10000
24 24.50 25 25.50 26
RLH806636-1 3154127c 1%NA Trem in Talc_chrys RLH806636-1 3154127b 1%NA Trem in Talc_chrys RLH806636-1 3154127a 1%NA Trem in Talc_chrys
0
5000
10000
11 12 13
RLH806636-1 3154127c 1%NA Trem in Talc_trem RLH806636-1 3154127b 1%NA Trem in Talc_trem RLH806636-1 3154127a 1%NA Trem in Talc_trem
ChrysotileTremolite Asbestos
2-theta2-theta
X-r
ay C
ount
s
X-r
ay C
ount
sReplicate 1Replicate 2Replicate 3
36
© 2019 USP
Mixing of talc base material + talc product mixture – for dilution to various concentrations
Final samples were thoroughly mixed:– Ground, spiked base material (talc + analyte), mixed with– Material used for diluting to appropriate concentration (mixture of various talc raw materials
received from suppliers which all tested negative for asbestos by TEM in 2010 FDA Survey.)
Flacktek® Speedmixer
Mixing efficiency demonstrated using Playdough®- From Flacktek® website
35
36
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
19
37
© 2019 USP
PLM Round Robin was a “Double-Blind” Study
Two-Step Approach
– Third party lab not involved with Expert Panel performed initial blinding and distribution of samples.
– USP received and compiled all results to maintain confidentiality between participants.
Significant time was expended to identify appropriate lab for blinding process and coordination of samples.
38
© 2019 USP
Next Steps…
Finalize draft method/General Chapters
Complete Stimuli Article
Begin Phase II evaluation of electron microscopy methods (TEM/SEM)
EM will be evaluated for potential false negative resolution; however, a systematic, scientific method validation will be performed before recommendation takes place.
37
38
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
20
39
© 2019 USP
YesYes
Concentration Method?
1. Evaluate the >5 um size fraction
Recommended Changes to USP Monograph:“Test for Asbestos”Phased Approach
No
EM (SEM, TEM)
Amphibole/SerpentineDetected?
AsbestosDetected(>0.01%)
Yes Amphibole/SerpentineAsbestos?
UnidentifiedSuspectFibers?
PLM
Wet Sieve Concentration
XRD Positive?
XRD Analysis
2. Evaluate the finer size fraction(Pending Phase II Evaluation)
No
No
Phase I Phase II Proposal
Report AsbestosContent
(Empirical DetectionLimit To be
Determined)
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
XRD Negative?
Amphibole/SerpentineDetected?
AsbestosNot Detected
(<0.01%)
PLM
Wet Sieve Concentration
No
Yes
39
40
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
21
Phone | Social Media | Email
41
42
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
22
43
© 2019 USP
To Be Considered (Phase II): Detection Limit
From EPA 600/R-93/116:
Detection Limit - The smallest concentration/amount of some component of interest that can be measured by a single measurement with a stated level of confidence.
Considerations regarding confidence in the measurement:
– Reproducibility
– Difference from background
– Unambiguous interpretation
44
© 2019 USP
To Be Considered: Background levels of asbestos
Lab blank programs indicate non-zero background levels.
100 blanks done with same parameters as analysis is required to prove 1 – 3 fibers is different than background (ASTM D6620).
Sources of contamination:– Earth’s crust is ~5% amphibole & serpentine is
common (state rock of California).
– Inorganic component of dust is similar to weathering products of rocks in the crust.
– Industrial use of asbestos (historic and present); asbestos is persistent.
– Safe drinking water standard allows 7 million asbestos fibers per liter of water.
– Air in rural areas = 10 fibers/m3*
– Air in urban areas = 100 fibers/m3*
*U.S. ATSDR: “10 fibers are typically presentin a cubic meter (fibers/m3 ) of outdoor air in rural areas. A cubic meter is about the amount of air that you breathe in 1 hour.”
ATSDR = Agency for Toxic Substances and Disease Registry
43
44
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION
3/30/2020
23
45
© 2019 USP
To Be Considered: Standard Reference Materials
Standard reference materials need to be developed
NIST standards for asbestos are no longer available
Reference talc base material should be defined
A low but detectable concentration should be created (by labs doing the analysis?) so that analysts can practice using the actual analyte in the actual matrix material.
0.1% or 0.05% (for PLM)?
46
© 2019 USP
Summary of Phase I Outcomes
XRD Result (Amphibole/Serpentine)
PLM Result Phase I Outcome
Not detected Amphibole/serpentine not detected <100 ppm
Not detected Asbestos not detected…and…Unidentified suspect fibers not detected
<100 ppm
Not detected Asbestos not detected…but…Unidentified suspect fibers detected
EM recommended(Phase II)
Not detected Asbestos detected >100 ppm
Detected Amphibole/serpentine not detected EM recommended(Phase II)
Detected Asbestos not detected…and…Unidentified suspect fibers not detected
<100 ppm
Detected Asbestos not detected…but…Unidentified suspect fibers detected
EM recommended(Phase II)
Detected Asbestos detected >100 ppm
45
46
CONFIDENTIAL -
NOT FOR D
ISTRIBUTION